Evidence map›Paper›PMID 39392278›Full record

ArticleFuture medicinal chemistry2024

Potent α-glucosidase inhibitors with benzimidazole-propionitrile hybridization; synthesis, bioassay and docking study.

Ebrahim Saeedian Moghadam, Abdullah Mohammed Al-Sadi, Mahdis Sadeghi Moghadam, Bahareh Bayati, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Mohsen Amini, Raid Abdel-Jalil

Abstract read
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Design, synthesis,RSC advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ebrahim Saeedian MoghadamDrug Design & Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Abdullah Mohammed Al-SadiDepartment of Crop Sciences, College of Agricultural & Marine Sciences, Sultan Qaboos University, PO Box 34, Al-Khod 123, Muscat, Sultanate of Oman.
Mahdis Sadeghi MoghadamDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran.
Bahareh BayatiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran.
Somayeh MojtabaviDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali FaramarziDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohsen AminiDrug Design & Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Raid Abdel-JalilDepartment of Chemistry, College of Science, Sultan Qaboos University, PO Box 36, Al-Khod 123, Muscat, Sultanate of Oman.

Funding

His Majesty's Trust FundTehran University of Medical Sciences and Health Services
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-GlucosidasesBenzimidazolesGlycoside Hydrolase InhibitorsHypoglycemic AgentsMolecular Docking SimulationBiological AssayHumansMolecular StructureNitrilesStructure-Activity Relationshipalpha-GlucosidasesbenzimidazoleBenzimidazolesGlycoside Hydrolase InhibitorsHypoglycemic AgentsNitrilesADMETbenzimidazolediabetes mellitusmolecular dockingnitrileα-glucosidase

Identifiers

PMID39392278
PMCPMC11622776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.